Cannabidiol Prevents Motor and Cognitive Impairments Induced by Reserpine in Rats
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cannabidiol Prevents Motor and Cognitive Impairments Induced by Reserpine in Rats
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 7, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2016-09-28
DOI
10.3389/fphar.2016.00343
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cannabidiol Post-Treatment Alleviates Rat Epileptic-Related Behaviors and Activates Hippocampal Cell Autophagy Pathway Along with Antioxidant Defense in Chronic Phase of Pilocarpine-Induced Seizure
- (2016) Mahshid Hosseinzadeh et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Cannabidiol Counteracts Amphetamine-Induced Neuronal and Behavioral Sensitization of the Mesolimbic Dopamine Pathway through a Novel mTOR/p70S6 Kinase Signaling Pathway
- (2016) Justine Renard et al. JOURNAL OF NEUROSCIENCE
- Co-administration of cannabidiol and capsazepine reduces L-DOPA-induced dyskinesia in mice: Possible mechanism of action
- (2016) Maurício dos-Santos-Pereira et al. NEUROBIOLOGY OF DISEASE
- Cannabidiol Modulates Fear Memory Formation Through Interactions with Serotonergic Transmission in the Mesolimbic System
- (2016) Christopher Norris et al. NEUROPSYCHOPHARMACOLOGY
- Highly specific changes in antioxidant levels and lipid peroxidation in Parkinson’s disease and its progression: Disease and staging biomarkers and new drug targets
- (2016) Carine Coneglian de Farias et al. NEUROSCIENCE LETTERS
- 6-Hydroxydopamine-Induced Dopamine Reductions in the Nucleus Accumbens, but not the Medial Prefrontal Cortex, Impair Cincinnati Water Maze Egocentric and Morris Water Maze Allocentric Navigation in Male Sprague–Dawley Rats
- (2016) Amanda A. Braun et al. NEUROTOXICITY RESEARCH
- Cognitive decline and quality of life in incident Parkinson's disease: The role of attention
- (2016) Rachael A. Lawson et al. PARKINSONISM & RELATED DISORDERS
- Molecular, Neurochemical, and Behavioral Hallmarks of Reserpine as a Model for Parkinson's Disease: New Perspectives to a Long-Standing Model
- (2015) Anderson H.F.F. Leão et al. BRAIN PATHOLOGY
- Neuroprotective potential of Beta vulgaris L. in Parkinson′s disease
- (2015) VandanaS Nade et al. INDIAN JOURNAL OF PHARMACOLOGY
- Cannabidiol increases survival and promotes rescue of cognitive function in a murine model of cerebral malaria
- (2015) A.C. Campos et al. NEUROSCIENCE
- Caffeine protects against memory loss induced by high and non-anxiolytic dose of cannabidiol in adult zebrafish (Danio rerio)
- (2015) Luiza Reali Nazario et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Tardive dyskinesia (syndrome): Current concept and modern approaches to its management
- (2015) Paul P. Lerner et al. PSYCHIATRY AND CLINICAL NEUROSCIENCES
- Behavioral and neurochemical effects induced by reserpine in mice
- (2015) Catiuscia Molz de Freitas et al. PSYCHOPHARMACOLOGY
- Extrapyramidal symptoms and cognitive test performance in patients with schizophrenia
- (2015) Gagan Fervaha et al. SCHIZOPHRENIA RESEARCH
- A systematic review of the antipsychotic properties of cannabidiol in humans
- (2015) Tabitha A. Iseger et al. SCHIZOPHRENIA RESEARCH
- Cannabidiol can improve complex sleep-related behaviours associated with rapid eye movement sleep behaviour disorder in Parkinson's disease patients: a case series
- (2014) M. H. N. Chagas et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Effects of cannabidiol in the treatment of patients with Parkinson’s disease: An exploratory double-blind trial
- (2014) Marcos Hortes N Chagas et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Effects of cannabinoid and vanilloid drugs on positive and negative-like symptoms on an animal model of schizophrenia: The SHR strain
- (2014) Valéria Almeida et al. SCHIZOPHRENIA RESEARCH
- Effects of cannabinoid drugs on the deficit of prepulse inhibition of startle in an animal model of schizophrenia: the SHR strain
- (2014) Raquel Levin et al. Frontiers in Pharmacology
- Cognitive, motor and tyrosine hydroxylase temporal impairment in a model of parkinsonism induced by reserpine
- (2013) José R. Santos et al. BEHAVIOURAL BRAIN RESEARCH
- Protective effect of nebivolol on reserpine-induced neurobehavioral and biochemical alterations in rats
- (2013) V.S. Nade et al. NEUROCHEMISTRY INTERNATIONAL
- Tardive dyskinesia is associated with greater cognitive impairment in schizophrenia
- (2013) Jing Qin Wu et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Cannabidiol attenuates catalepsy induced by distinct pharmacological mechanisms via 5-HT1A receptor activation in mice
- (2013) Felipe V. Gomes et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Cognition impairment in schizophrenia patients with tardive dyskinesia: Association with plasma superoxide dismutase activity
- (2013) Jing Qin Wu et al. SCHIZOPHRENIA RESEARCH
- Repeated treatment with a low dose of reserpine as a progressive model of Parkinson's disease
- (2012) Valéria S. Fernandes et al. BEHAVIOURAL BRAIN RESEARCH
- Current Options and Future Possibilities for the Treatment of Dyskinesia and Motor Fluctuations in Parkinson's Disease
- (2012) M. A. Cenci et al. CNS & Neurological Disorders-Drug Targets
- Antipsychotic Profile of Cannabidiol and Rimonabant in an Animal Model of Emotional Context Processing in Schizophrenia
- (2012) Raquel Levin et al. CURRENT PHARMACEUTICAL DESIGN
- Cannabidiol reduces host immune response and prevents cognitive impairments in Wistar rats submitted to pneumococcal meningitis
- (2012) Tatiana Barichello et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Cannabidiol exhibits anxiolytic but not antipsychotic property evaluated in the social interaction test
- (2012) Valéria Almeida et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Spatial memory, plasticity and nucleus accumbens
- (2012) Arianna Rinaldi et al. REVIEWS IN THE NEUROSCIENCES
- Neuroprotective effects of phytocannabinoid-based medicines in experimental models of Huntington's disease
- (2011) Onintza Sagredo et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Evaluation of Markers of Oxidative Stress, Antioxidant Function and Astrocytic Proliferation in the Striatum and Frontal Cortex of Parkinson’s Disease Brains
- (2011) Rajeswara Babu Mythri et al. NEUROCHEMICAL RESEARCH
- Gene–environment interactions: Key to unraveling the mystery of Parkinson's disease
- (2011) Hui-Ming Gao et al. PROGRESS IN NEUROBIOLOGY
- Memory-rescuing effects of cannabidiol in an animal model of cognitive impairment relevant to neurodegenerative disorders
- (2011) Elen V. Fagherazzi et al. PSYCHOPHARMACOLOGY
- Treatment with cannabidiol reverses oxidative stress parameters, cognitive impairment and mortality in rats submitted to sepsis by cecal ligation and puncture
- (2010) Omar J. Cassol-Jr et al. BRAIN RESEARCH
- Antidepressant-like effect of Δ9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L.
- (2010) Abir T. El-Alfy et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Tardive dyskinesia and new antipsychotics
- (2009) Christoph U Correll et al. CURRENT OPINION IN PSYCHIATRY
- A behavioural comparison of acute and chronic Δ9-tetrahydrocannabinol and cannabidiol in C57BL/6JArc mice
- (2009) Leonora E. Long et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Cannabidiol ameliorates cognitive and motor impairments in mice with bile duct ligation
- (2009) Iddo Magen et al. JOURNAL OF HEPATOLOGY
- Effects of cannabidiol on amphetamine-induced oxidative stress generation in an animal model of mania
- (2009) Samira S Valvassori et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb
- (2009) Angelo A. Izzo et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Cannabidiol for the treatment of psychosis in Parkinson’s disease
- (2008) AW Zuardi et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Free Copper, Ferroxidase and SOD1 Activities, Lipid Peroxidation and NO x Content in the CSF. A Different Marker Profile in Four Neurodegenerative Diseases
- (2008) Marie-Catherine Boll et al. NEUROCHEMICAL RESEARCH
- Memory impairment induced by low doses of reserpine in rats: Possible relationship with emotional processing deficits in Parkinson disease
- (2008) Valéria S. Fernandes et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action
- (2008) Antonio Waldo Zuardi REVISTA BRASILEIRA DE PSIQUIATRIA
- Cannabidiol potentiates pharmacological effects of Δ9-tetrahydrocannabinol via CB1 receptor-dependent mechanism
- (2007) Kazuhide Hayakawa et al. BRAIN RESEARCH
- Plasma lipid peroxidation and antioxidant status of Parkinson's disease patients in the Indian population
- (2007) Aabha Sharma et al. PARKINSONISM & RELATED DISORDERS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started